Cyxone Submits First Application to Start Clinical Phase IIb Trial With Rabeximod

By In The News
July 5, 2019 in The Headlines

Recommended Posts

In The News

Posted July 5, 2019

- Share

Posted July 5, 2019

STOCKHOLM, July 5, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today submitted an application to the Central Ethics Committee (CEC) in Poland for permission to start a clinical phase IIb trial with its drug candidate Rabeximod, which is in development for ...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221945
2. Jaydee
  17742
3. deicer
  13314
4. Kip Powick
  12306
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.3k
- Total Posts
  
  564.8k

Sign In

Cyxone Submits First Application to Start Clinical Phase IIb Trial With Rabeximod

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support